TRXE-002-1 (Cantrixil) Toxicology, page-23

The short answer - and in fact the reality is rikkki - the purpose and timing of the CR was to fund the company sufficiently into Phase 2 trials so that the true effect of the SPB drugs might become known.

Regardless of what has happened since, the legacy of Dr Kelly's leadership - or spruiking as you crudely call it - has guaranteed the company the opportunity to find out if the drugs do in humans as they do in pre-clinical trials.

I think the answer will be yes - given that the older drugs now in the hands of MEI Pharma have helped Graham to overcome his cancer.

His stated desire is to do for others as he has been able to do for himself.